Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir^® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)

Relevanc. Measles, mumps and rubella, despite many years of vaccination, retain their epidemiological and social significance at the present time. The aim of the work is to study the safety and immunogenicity. Of the vaccine for the prevention of measles, rubella and mumps Vactrivir® in children's i...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	I. V. Feldblium, V. V. Romanenko, K. A. Subbotina, M. G. Menshikova, I. A. Okuneva, A. Y. Musikhina, T. E. Snitkovskaya, N. I. Marcovich, A. E. Ershov, D. M. Trofimov
Aineistotyyppi:	Artigo
Kieli:	Russo
Julkaistu:	Numikom LLC 2021-03-01
Sarja:	Эпидемиология и вакцинопрофилактика
Aiheet:	measles rubella mumps children reactogenicity, safety immunogenicity
Linkit:	https://www.epidemvac.ru/jour/article/view/1177
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!